Medipharm Labs Corp's stock has seen a notable decline this week, despite some recent company developments.
This week, Medipharm Labs Corp (LABS.TO) experienced a 6.25% drop in its stock price, closing at C$0.07. The company made headlines with its first shipment to France, marking a significant entry into the European medicinal cannabis market. However, this progress hasn't been enough to prevent the stock from facing downward pressure.
Advertisement
Medipharm Labs Corp
LABS.TO
LABS.TO
Medipharm Labs Corp
WealthAwesomeMarket cap
$29.90M
52W high
$0.10
52W low
$0.06
1W change
+0.00%
Beta
0.85
Analyst Price Targets
Based on analyst covering LABS · as of Sep 17, 2026
Wall Street analysts forecast LABS stock price to rise 42.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.10
+42.9% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LABS's historical volatility
30-Day Vol
61.1%
Annualized
90-Day Vol
73.7%
Annualized
Trend (90d)
-29.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.08 |
| 60 trading days | C$0.07 | C$0.05 – C$0.09 |
| 90 trading days | C$0.06 | C$0.04 – C$0.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should consider the potential of Medipharm Labs' international expansion against the ongoing financial challenges reflected in its performance metrics. With a market cap of about C$32 million and a negative profit margin, it's wise to proceed with caution if you're looking into this stock.
C$0.07 closing price reflects a 6.25% decline this week.
The stock's current price is at 37% of its 52-week range of C$0.06 to C$0.10, indicating a relatively low trading price within its historical context.
Bull case
The successful shipment to France positions Medipharm Labs to tap into a growing international market for medicinal cannabis. This could enhance revenue streams and improve the company's overall financial performance.
Bear case
Despite the recent positive developments, Medipharm Labs continues to report negative profit margins and lacks immediate financial results. These factors may deter investors in an uncertain market environment.
Recent Price Action
Advertisement
Medipharm Labs Corp's stock closed at C$0.07, reflecting a 6.25% decline over the past week. The stock has traded within a 52-week range of C$0.06 to C$0.10, indicating it is currently positioned at 37% of this range.
Company News and Developments
This week, Medipharm Labs announced the successful completion of its first shipment to France, marking a significant step into the European medicinal cannabis market. This development is seen as a positive catalyst for the company’s growth strategy, allowing it to leverage new revenue opportunities in international markets.
Technical Picture
The technical indicators for Medipharm Labs show a last close of C$0.07, with the 50-day moving average at C$0.08, indicating slight underperformance relative to this average. The 200-day moving average is C$0.07, suggesting stability in longer-term price trends. The stock has a beta of 0.93, indicating lower volatility compared to the broader market. Recent trading volume was 11,662 shares, which is approximately 1.19 times the 20-day average volume of 174,492 shares.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
